Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells
C. D’Avino(University of Naples Federico II), Claudia De Lorenzo(Istituto Nazionale di Fisica Nucleare, Sezione di Napoli), Ronald T. Raines(Broad Institute), M. Coppola(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gennaro Riccio(Sapienza University of Rome), Paolo Laccetti(University of Naples Federico II), Nicola Maurea(Cancer Institute (WIA)), Rolando Paciello(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy))
Cited by 17
Related Papers
Fish Waste: From Problem to Valuable Resource
|Marine Drugs|2021|568
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Microalgae with Immunomodulatory Activities
|Marine Drugs|2019|184
The CXXC motif: imperatives for the formation of native disulfide bonds in the cell.
|The EMBO Journal|1996|175
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116